Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Medicare cost containment strategy targets several oncology drugs.

Twombly R.

J Natl Cancer Inst. 2004 Sep 1;96(17):1268-70. No abstract available.

PMID:
15339960
2.

Molecular medicine, the Medicare drug benefit, and the need for cost control.

Gillick MR.

J Am Geriatr Soc. 2006 Sep;54(9):1442-6. Review.

PMID:
16970656
3.

The Medicare Prescription Drug Improvement and Modernization Act and the delivery of cancer chemotherapy.

Downs C.

Am J Health Syst Pharm. 2007 Aug 1;64(15 Suppl 10):S13-5; quiz S21-S23. Review.

PMID:
17646548
4.

Pharmaceutical reimbursement: an overview.

Johnson PE.

Am J Health Syst Pharm. 2008 Jan 15;65(2 Suppl 1):S4-10. Review.

PMID:
18192246
5.

European perspective on the costs and cost-effectiveness of cancer therapies.

Drummond MF, Mason AR.

J Clin Oncol. 2007 Jan 10;25(2):191-5. Review.

PMID:
17210939
6.
7.

Should the medicare ESRD program pay for daily dialysis? An ethical analysis.

Anantharaman P, Moss AH.

Adv Chronic Kidney Dis. 2007 Jul;14(3):290-6. Review.

PMID:
17603984
8.

Oncology enters the informatics era.

Klein IM.

Am J Manag Care. 2012 Dec;18(5 Spec No.):SP218-21. Review. No abstract available.

9.

[Prescription of high-cost medicines in French Hospitals: Regulation and procedures of reimbursement].

Wilkowsky C, Lenain A, Benbekhaled K, Le Gall MJ, Vignot S.

Bull Cancer. 2016 Apr;103(4):353-60. doi: 10.1016/j.bulcan.2016.02.010. Epub 2016 Mar 24. Review. French.

PMID:
27017057
10.

Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.

Taylor RS, Drummond MF, Salkeld G, Sullivan SD.

BMJ. 2004 Oct 23;329(7472):972-5. Review. No abstract available.

11.

[How do guidelines have an effect on the cost reimbursement? ].

Krome S.

Dtsch Med Wochenschr. 2011 Feb;136(8):355. doi: 10.1055/s-0031-1275155. Epub 2011 Feb 23. Review. German. No abstract available.

PMID:
21348004
12.

Six strategies to identify and assist patients burdened by out-of-pocket prescription costs.

Alexander GC, Tseng CW.

Cleve Clin J Med. 2004 May;71(5):433-7. Review.

PMID:
15195778

Supplemental Content

Support Center